Leaky gut is not an autoimmune disease. It is a breakdown in the intestinal barrier that can contribute to autoimmune diseases, but it is not classified as one itself. Think of it as a condition of the gut lining, not a disease of the immune system, though the two are deeply connected.
The distinction matters because it changes how you think about what’s happening in your body. Autoimmune diseases like celiac disease, rheumatoid arthritis, and multiple sclerosis involve the immune system attacking healthy tissue. Leaky gut describes the structural failure that can let that process get started in the first place.
What Leaky Gut Actually Is
Your intestinal lining is a single layer of cells held together by structures called tight junctions. These junctions act like gatekeepers, allowing nutrients through while blocking bacteria, undigested food proteins, and toxins from entering your bloodstream. When those junctions loosen, the barrier develops gaps. Particles that would normally be eliminated from the body slip into circulation, where they trigger an immune response. That’s leaky gut: a dysfunctional barrier, not a disease in its own right.
Leaky gut does not have an official diagnostic code in the medical classification system. It’s recognized in research as “increased intestinal permeability,” a measurable physiological state rather than a standalone diagnosis. This is part of why it sits in a gray area. Mainstream gastroenterologists acknowledge that barrier dysfunction exists and plays a role in disease, but there’s no consensus on treating it as its own condition.
How It Connects to Autoimmune Disease
The traditional model of autoimmune disease has two ingredients: a genetic predisposition and an environmental trigger. Research over the past two decades has added a third: a damaged gut barrier. The idea is that even if you carry genes that make you susceptible to an autoimmune condition, the disease may not develop unless your intestinal barrier breaks down and exposes your immune system to the wrong molecules.
A protein called zonulin is central to this process. Your body produces zonulin naturally, and its job is to regulate tight junctions, opening and closing them as needed. But when zonulin levels rise too high, tight junctions disassemble more than they should, and the gut becomes permeable. In people with celiac disease, blood levels of zonulin are significantly elevated. Interestingly, people with non-celiac gluten sensitivity show zonulin levels almost as high as those with celiac disease itself.
The autoimmune conditions linked to increased gut permeability span well beyond the digestive tract. They include celiac disease, inflammatory bowel disease, autoimmune hepatitis, rheumatoid arthritis, multiple sclerosis, and type 1 diabetes. People with rheumatoid arthritis, and even those in a “pre-RA” stage (meaning they have elevated autoantibodies but no active disease yet), show higher zonulin levels compared to healthy controls. Those elevated levels correlate with visible changes in the gut barrier under microscopy. This suggests the barrier may break down before the autoimmune disease fully develops.
Symptoms That Overlap and Confuse
Part of the reason people wonder whether leaky gut is an autoimmune disease is that its symptoms are broad and overlapping. Increased intestinal permeability has been associated with food sensitivities, bloating, fatigue, joint pain, skin conditions like psoriasis, asthma, and allergies. Many of these are also hallmarks of autoimmune conditions, which makes it difficult to tell whether you’re experiencing gut barrier dysfunction, an autoimmune disease, or both.
Digestive symptoms like bloating, gas, and abdominal discomfort tend to be more localized signs of barrier dysfunction. Systemic symptoms, like joint pain, brain fog, or skin rashes, suggest that the immune response has spread beyond the gut. One UCLA clinician described diagnosing a 79-year-old patient who had been misdiagnosed with irritable bowel syndrome for more than two decades, when the underlying issue involved barrier dysfunction. Misdiagnosis is common because there’s no single symptom that points clearly to increased permeability.
How Gut Permeability Is Measured
There is a clinical test for intestinal permeability, though it’s used more in research than in routine medical practice. The lactulose-mannitol test works by having you drink two sugar molecules of different sizes. Mannitol is small and passes through the intestinal wall easily in a healthy gut. Lactulose is larger and should mostly be blocked. You then collect urine for several hours, and the ratio of the two sugars reveals how permeable your gut lining is. A high lactulose-to-mannitol ratio signals barrier dysfunction.
The standard version requires a five-hour urine collection, which is inconvenient enough that some researchers have tested a two-hour version with comparable results. Zonulin blood levels are also being explored as a simpler biomarker, though they haven’t yet become a routine clinical tool.
What Damages the Gut Barrier
Several factors can degrade tight junction integrity. Gluten is the best-studied trigger: in celiac disease, gliadin peptides (fragments of gluten) directly stimulate zonulin release, which opens tight junctions and allows more gluten fragments through, creating a self-reinforcing cycle of permeability and immune activation.
Diet plays a broader role than just gluten. Ultra-processed foods contain additives that have been shown in preclinical studies to affect the gut barrier. Emulsifiers, common in packaged foods, alter the structure of the intestinal mucus layer that serves as the gut’s first line of defense. Artificial sweeteners can disrupt tight junctions by activating sweet taste receptors on intestinal cells. Chronic stress, alcohol, nonsteroidal anti-inflammatory drugs, and infections can also increase permeability.
Approaches to Restoring the Barrier
Because leaky gut is a structural problem rather than a disease, management focuses on removing what’s damaging the barrier and supporting its repair. For people with celiac disease, a strict gluten-free diet is the primary intervention, though some patients continue to have symptoms and elevated permeability even while avoiding gluten.
The amino acid glutamine is the most studied nutritional support for tight junction repair. It’s the primary fuel source for the cells lining the intestine. In hospitalized patients, doses above 0.25 to 0.3 grams per kilogram of body weight per day showed the greatest benefit for barrier function. Glutamine-based oral rehydration solutions have also demonstrated barrier repair benefits in patients with diarrhea, beyond simple rehydration.
On the pharmaceutical side, a drug called larazotide acetate blocks the zonulin pathway and has shown promising results across multiple human trials. In celiac disease patients exposed to gluten, it improved gastrointestinal symptoms and reduced markers of immune activation. In preclinical models, it reduced intestinal permeability in colitis, attenuated arthritis severity, and decreased inflammation in lung injury. It’s currently being tested in phase II trials for additional conditions. If it proves effective at scale, it would represent the first drug specifically designed to restore gut barrier function rather than suppress the immune system after the damage is done.
Why the Distinction Matters
Calling leaky gut an autoimmune disease would put it in the wrong category and point toward the wrong treatments. Autoimmune diseases are typically managed by dampening immune activity. Leaky gut, by contrast, is about fixing a physical barrier. The emerging model suggests that restoring that barrier could potentially prevent or reduce autoimmune flares, rather than just managing symptoms after the immune system has already gone haywire.
This reframing also explains why some people improve autoimmune symptoms through dietary changes alone. If the gut barrier is a gatekeeper, and certain foods are propping the gate open, removing those foods can reduce the antigenic load reaching the immune system. It’s not a cure for the underlying genetic susceptibility, but it can reduce the trigger that turns susceptibility into active disease.